Micallef Jacob Vincent 4
4 · VOLITIONRX LTD · Filed Dec 18, 2019
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Micallef Jacob Vincent
Chief Scientific Officer
Transactions
- Award
Option (Right to Buy)
2019-12-16+66,533→ 70,000 totalExercise: $5.00From: 2019-12-16Exp: 2023-03-30→ Common Stock (66,533 underlying) - Disposition to Issuer
Option (Right to Buy)
2019-12-16−66,533→ 3,467 totalExercise: $5.00From: 2018-03-30Exp: 2023-03-30→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person. The "old" options were originally granted on March 30, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested on the date of grant and have the same expiration date and exercise price as the "old" options.